Seven classes of antiviral agents
Aleksandr Ianevski, Shahzaib Ahmad, Kraipit Anunnitipat, Valentyn Oksenych, Eva Žusinaite, Tanel Tenson, Magnar Bjørås, Denis E. Kainov
Norwegian University of Science and Technology University of Tartu University of Helsinki Institute for Molecular Medicine Finland
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
The viral epidemics and pandemics have stimulated the development of known and the discovery of novel antiviral agents. About a hundred mono- and combination antiviral drugs have been already approved, whereas thousands are in development. Here, we briefly reviewed 7 classes of antiviral agents: neutralizing antibodies, neutralizing recombinant soluble human receptors, antiviral CRISPR/Cas systems, interferons, antiviral peptides, antiviral nucleic acid polymers, and antiviral small molecules. Interferons and some small molecules alone or in combinations possess broad-spectrum antiviral activity, which could be beneficial for treatment of emerging and re-emerging viral infections.
逐年被引趋势
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
生物医学interferon and immune responses
SARS-CoV-2 and COVID-19 Research · Virology and Viral Diseases